← Leaderboards
Nazish Sayed
Stanford University
$4,856,076
Attributed
$5,456,206
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,456,206 · 4
By mechanism
R01$3,728,225 · 2
UG3$900,195 · 1
K01$827,786 · 1
Top collaborators
- Joseph C Wu1 shared
- James Zou1 shared
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Thomas None Quertermous$63,279,401
- Jayakumar Rajadas$2,361,651
- Elizabeth Susan Sattely$6,246,816
- Mark Mercola$44,191,191
Others in their field
Other Emerging Leaders on “Cardiac Myocytes”
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Zhao Wang · Ut Southwestern Medical Center$7,466,347
- Wuqiang Zhu · Mayo Clinic Arizona$6,841,350
- Toren Finkel · Heart, Lung, And Blood Institute$5,986,740
- Matthew A Nystoriak · University Of Louisville$5,796,126
- Xi Fang · University Of California, San Diego$5,655,788
Research focus
Cardiac MyocytesInduced Pluripotent Stem CellHeart FailureEndothelial CellsImpairmentAffectPathogenesisMolecularPhenotypeHeartPositioning AttributeEnvironmentFunctional DisorderCrispr/Cas TechnologyComplexGenome EditingMorbidity - Disease RateMortalitySiteGenesCardiacInduced Pluripotent Stem Cell TechnologyInterdisciplinary ApproachCells
Grant awards (17)
AI-driven Drug Discovery Targeting Cardiac Fibrosis in Aging Heart$900,195
UG3 · FY2025 · AG
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity$394,436
R01 · FY2025 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$394,214
R01 · FY2025 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$394,193
R01 · FY2024 · HL · contact PI
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity$393,500
R01 · FY2024 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$91,843
R01 · FY2024 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$394,173
R01 · FY2023 · HL · contact PI
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity$393,500
R01 · FY2023 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$91,866
R01 · FY2023 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$393,500
R01 · FY2022 · HL · contact PI
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity$393,500
R01 · FY2022 · HL · contact PI
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy$393,500
R01 · FY2021 · HL · contact PI
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy$157,793
K01 · FY2021 · HL · contact PI
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy$161,558
K01 · FY2020 · HL · contact PI
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy$165,440
K01 · FY2019 · HL · contact PI
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy$169,439
K01 · FY2018 · HL · contact PI
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy$173,556
K01 · FY2017 · HL · contact PI